Dilated cardiomyopathy due to novel LMNA mutation: a case report

Front Cardiovasc Med. 2024 Oct 1:11:1422151. doi: 10.3389/fcvm.2024.1422151. eCollection 2024.

Abstract

A case of a 44-year-old man presenting with a family history of LMNA mutation and cardiac symptoms (dizziness, weakness, palpitations, and shortness of breath) congruent with dilated cardiomyopathy. Genetic testing revealed a novel likely pathogenic mutation of the LMNA gene (c.513G>A, exon 2) not previously associated with dilated cardiomyopathy, and the patient underwent guideline direct treatment for dilated cardiomyopathy. In patients with LMNA mutations, VTA risk should be calculated to determine the need for prophylactic ICD placement.

Keywords: ICD; LMNA mutation; case report; dilated cardiomyopathy; sudden cardiac death.

Publication types

  • Case Reports

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.